Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Ma S et al 2013 China | 1) Surveillance n = 120 2) Serial samples n=76 18 years Less than 12 weeks pregnant Chief complaint of bleeding or abdominal pain | Two independent cross-sectional studies ED conducted | Contamination rates from twice daily swabs for 60 days PCR for DNA detection of HPV | HPV detection (n = 120) 7,5% CI not specified Contamination higher in days 1-20 (20%) | Not blinded Little sample size Coupling gel not analysed No testing for viral load Dry cotton wool swabs stored in normal saline (loss in sensitivity) 3 consecutive swabs on probe might increase contamination by operator manipulations |
Contamination rates (disinfection procedure : condoms removal, dry wipe then T-spray application) PCR for DNA detection of HPV | HPV detection before disinfection : 1 (1,2% CI not specified) HPV detection after disinfection in HPV positive patients on high vaginal swab (n=14): 3 | ||||
M’Kazil F et a 2014 France | 300 Consecutive swabs of vaginal ultrasound probes | Prospective 1 private radiology center | Contamination rate after removal of CE disposable sheaths, sterile dry wipe and disinfection with Prodene wipes PCR DNA detection | HPV (n=100): 13% (95% CI 6-20) Chlamydia trachomatis (n=100) 20% (95% CI 12-28) Mycoplasma 8% (95% CI 3-13) Commensal and/or environmental bacterial flora 86% (95% CI 79-93%) S. coagulase-Negative 73% S aureus 4% Streptococcus viridans 2% | Consecutive samples but not all three analysis performed in every sample Financial support by Germitec |
Second PCR amplification after DNase treatment in positive sample (identification of infectious viral or bacterial particles) | HPV 7% (95% CI: 2– 12) Mycoplasmas 4% (95% CI: 0–8) C. trachomatis 2% (95% CIX-X) | ||||
Ultrasound gel | Analysis 1/week: no significant microbial contamination | ||||
Casalegno et al 2012 France | Probe swab samples 1) After probe disinfection (n=200) 2) Before scan n=217 | Prospective 2 studies Gynecology ward CE disposable probe cover Disinfection of probe by nurse under technician supervision | HPV after disinfection with Sani-Cloth active PCR for DNA detection of HPV | HPV (n=198): 3,5% Sampling order : 4 subsequent samples positive for the same HPV type. | Not blinded Dry swabs : loss in sensitivity No testing for viral load Funded by Germitec |
HPV before probe use PCR for DNA detection of HPV | HPV (n=216) : 2,8% | ||||
Storment JM, 1997 United States | 173 women Diagnosis of threatened spontaneous abortion (n=118) possible ectopic pregnancy (n=30) pelvic pain (n=20) and pelvic mass (n=5) | Prospective Obstetrics and gynecology residents performing transvaginal ultrasound in the ED | Contamination inside condom | Blood or vaginal fluid visualized on probe : 3 (2%) Contamination of probe (hydrogen peroxide poured into condom, bubbling when in contact with secretions or blood) : 8 (5%) | Blood or vaginal fluid visualized on probe : 3 (2%) Contamination of probe (hydrogen peroxide poured into condom, bubbling when in contact with secretions or blood) : 8 (5%) |
Bénet et al. 2014 France | Patients tested for HIV : 50 244 (Prevalence seropositivity : 1,4 %) Tested for HCV : 105 995 (Prevalence seropositivity : 3%) | Prospective cohort of all patients tested for HIV and HCV Single center (Lyon Hospital) Endovaginal, transrectal and transoesophageal exposures | Multivariate logistic regression adjusted for sex, age and time period | HIV prevalence not associated with previous endocavitary probe exposure (p=0,18) | Endocavitary exposure 12 months prior to testing Type of probe cover and methods of disinfection at Lyon’s Hospital not specified Ultrasounds performed in the emergency department included ? Confounder not taken into account: iv drug use, blood products transfusion |
One or more endovaginal probe exposure prevalence and adjusted odds ratio | HIV prevalence 0,5% HCV prevalence: 1,3% HIV aOR : 1,1 (95% CI 0,4-2,6) HCV aOR : 0,8 (95% CI 0,5-1,3) | ||||
Relative risk of seroconversion HCV in patient previously exposed to endocavitary probe | RR 0,7 (95% CI 0,1-4,8, p=0,69) | ||||
Amis S et al 2000 United Kingdom | 214 scans of women referred to Ovarian Cancer Screening Clinic | Prospective | Contamination of probe by routine bacterias and HSV-1 HSV-2 Transducer uncovered and wiped with a dry tissue | Bacterial swabs n =24 Viral sample n=11 1 positive for Acinetobacter sp | Swabs samples not taken systematically Criteria for sampling not specified. Not blinded |
Contamination by routine bacterias and HSV-1 HSV-2 Transducer uncovered and wiped with dry tissue then 70% v/v isopropyl alcohol wipe | Bacterial swabs n=22 Viral swabs n=15 No bacterial /viral growth | ||||
Condoms perforation | N=214 2 noted upon visual inspection 204 tested with hydrogen peroxide : no perforation | ||||
Sonographic coupling gel | N=25 No growth | ||||
Leroy S 2013 France | - | Systematic review Meta-analysis | Pooled estimate of probe contamination for transvaginal ultrasound after low level disinfection of probe (dry towel then towel combined to a disinfectant) | Prevalence of bacterial contamination (N=596) Pooled prevalence 12,9% (95% CI 1,7-24,3) Bacterias: Enterobacter sp, Acinetobacter sp, P aeruginosa, C cepacia, E Coli, S aureu Viral contamination (N=408) 1% (95% CI 0-10) HSV, CMV, HPV | Quality evaluation (eg PRISMA) of studies not presented Pooled prevalence not weighted for sample size Physician performing the ultrasound not specified |
Kac G et al., 2010 France | Bacterial analysis n =122 Viral analysis n = 336 | Prospective 3 radiology wards | Rate of bacterial contamination | Positive bacterial cultures after transvaginal examination (n=122) 3 2,5% (95%CI 0,5-7,3%)(Pseudomonas sp, Klebsiella pneumoniae) | No testing for viral load No explanation for difference in sample size between viral and bacterial contamination Bacterial load after UVC light disinfection not mentioned 2 types of probe covers (condoms n=267 and probe sheaths n=173) Ultrasound gel not analysed Swabs taken after probe cover removal but before cleaning with a towel impregnated with a disinfectant spray Financial support by Germitec |
Rate of viral contamination EBV, CMV, HPV | Viral analysis (transvaginal = 90 ; transrectal n= 336) before probe removal Presence of at least 1 virus: 56 (16,7% 95%CI 13,1-21%) HPV 28 (8,3% CI not specified) Presence of viral genome in 5 (8,9% 95% CI 3,5-19,7%) of the 56 virally contaminated After removal of probe cover 1 EBV (transvaginal) | ||||
Evaluate efficacy of disinfection combined to UVC light | No viral genome detected |